About Cyntellect
Cyntellect is a company based in San Diego (United States) founded in 1997. It operates as a B2B. Cyntellect has raised $48.81 million across 10 funding rounds from investors including Third Security and National Science Foundation. Cyntellect operates in a competitive market with competitors including Cytek Biosciences, Accuri Cytometers, ACEA Biosciences, Bioaffinity technologies and NanoFCM, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$48.81 M (USD)
in 10 rounds
-
Latest Funding Round
$9 M (USD), Series E
May 14, 2010
-
Investors
Third Security
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cyntellect
Cyntellect has successfully raised a total of $48.81M across 10 strategic funding rounds. The most recent funding activity was a Series E round of $9 million completed in May 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cyntellect
Cyntellect has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Third Security and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Late-stage venture capital is provided to US life sciences companies.
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Cyntellect
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cyntellect
Investment portfolio details for Cyntellect
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cyntellect
Detailed financials for Cyntellect
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cyntellect Comparisons
Peer comparison for Cyntellect
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cyntellect
Cyntellect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytek Biosciences, Accuri Cytometers, ACEA Biosciences, Bioaffinity technologies and NanoFCM, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Advanced flow cytometry systems are manufactured for research applications.
|
|
| Locked | Locked | Locked |
Compact flow cytometers for cell analysis are developed and provided.
|
|
| Locked | Locked | Locked |
Instruments for life science research are developed and marketed.
|
|
| Locked | Locked | Locked |
IVD platforms are developed to detect and target cancer cells.
|
|
| Locked | Locked | Locked |
Offers advanced tools for nanoparticle analysis in biotechnology and healthcare.
|
|
| Locked | Locked | Locked |
Instrumentation for cell and protein analysis is developed and marketed.
|
Detailed competitors of Cyntellect
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cyntellect
Complete news archive for Cyntellect
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cyntellect
Cyntellect was founded in 1997 and raised its 1st funding round 8 years after it was founded.
Cyntellect is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Cyntellect is a funded company, having raised a total of $48.81M across 10 funding rounds to date.
Cyntellect offers technology for cell analysis, purification, and processing through advancing biotech innovations, life sciences, cell analysis, and purification technology. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Cyntellect's top competitors include Cytek Biosciences, Bioaffinity technologies and Accuri Cytometers.
Cyntellect has 2 investors. Key investors include Third Security, and National Science Foundation.